CTOs on the Move

Caladrius

www.caladrius.com

 
Caladrius is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of cell therapies designed to reverse disease and/or promote the regeneration of damaged tissue. The Company is developing first-in-class therapeutics based on the characteristics of naturally occurring CD34+ cells and their ability to stimulate the growth of new microvasculature. The Company`s platform technology leverages these cells to enable the body`s natural repair mechanisms using formulations unique to each medical indication.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.caladrius.com
  • 110 Allen Road 2nd Floor
    Basking Ridge, NJ USA 07920
  • Phone: 908.842.0100

Executives

Name Title Contact Details
Greg Berkin
 Vice President of Information Technology & Cybersecurity and Chief Information Officer Profile

Funding

Caladrius raised $25M on 01/21/2021
Caladrius raised $65M on 02/12/2021

Similar Companies

Hazel Technologies

Hazel Technologies develops products that extend the shelf life of produce. Our customers include some of the largest produce growers in the world.

Altimmune

Altimmune is a clinical-stage immunotherapeutics company focused on the development of products to stimulate robust and durable immune responses for the prevention and treatment of infectious disease.

Quintessence Biosciences Inc

Quintessence Biosciences Inc is a Madison, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Optherion Inc

Optherion Inc is a New Haven, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

FluroTech

FluroTech is a technology and marketing company whose core business is focused on the commercialization of new technologies in the cannabis industry. FluroTech`s proprietary spectroscopy-based technology allows for the testing and identification of organic and inorganic compounds contained within biological samples derived from cannabis plants. Using the technology that was developed at the University of Calgary in conjunction with the University of Alberta, FluroTech has developed a two-part solution comprising an instrument called the CompleTest™ and consumable testing kits.